One fun fact to round off this post: Takeda Pharma will be the first listed company in Japan to be run by a non-Japanese woman. Current CEO Christophe Weber has handpicked Julie Kim to become his successor in 2026. She’s heading US operations, so Takeda’s most important market. She hails from Shire, the company Takeda acquired in 2019.
Japanese business is some of the most untrustworthy anywhere - the Ghosn case showed the world this. There's no there, there - it's self interest and paranoia from an island people whose very modern existence was borrowed and stolen directly from westerners.
One fun fact to round off this post: Takeda Pharma will be the first listed company in Japan to be run by a non-Japanese woman. Current CEO Christophe Weber has handpicked Julie Kim to become his successor in 2026. She’s heading US operations, so Takeda’s most important market. She hails from Shire, the company Takeda acquired in 2019.
Japanese business is some of the most untrustworthy anywhere - the Ghosn case showed the world this. There's no there, there - it's self interest and paranoia from an island people whose very modern existence was borrowed and stolen directly from westerners.